Tropocells Powered by Eclipse

With over 800,000 patient cases worldwide since 2013, Eclipse is recognized as the trusted leader in Platelet-Rich Plasma technology.

Features & Benefits

Vacuum sealed, internally coated glass tube designed to:

  • Prevent platelets from“sticking” to tube walls
  • Precisely draw blood at a pressure that prevents lysing of the cells

Proprietary anti-coagulant (MNC7) modified to:

  • Reduce acidity while preventing coagulation of platelets
  • Deliver non-activated platelets physically positioned on top of gel

Separator gel designed to:

  • Spare up to 80% (+/-9%) of platelets
  • Remove 99.9% of RBC
  • Remove 95% of granulocytes
  • Nearly 0% Red Blood Cells
  • Lowest possible White Blood Cell count
  • Physiologic pH (less irritation at point of care)
  • Low volume blood draws (lends itself to consecutive treatments)
  • Reproducible among multiple staff people
  • Consistent performance on every case
  • The Best Price/Platelet Yield Ratio

High Concentration Made Simple

Eclipse Easy Spin Process

Collect Patients Blood
(11ml or 22ml tube) 

Eclipse Easy Spin Process

Centrifuge (10 min.) 

Eclipse Easy Spin Process

Extract Platelet Poor Plasma (PPP)

Eclipse Easy Spin Process

Collect Platelet Rich Plasma (PRP) and apply

Why Tropocells PRP

Tropocells PRP, powered by Eclipse, takes out the complexities of platelet-rich plasma (PRP) preparation processing. It delivers a highly purified platelet concentrate that preserves platelets and removes nearly all red blood cells and neutrophil cells that promote inflammation and catabolism.

High Concentration

80% (+/- 9%) Platelet Yield + customizable concentrations
up to 4.5x

Safe & Autologous

FDA Cleared 510(k) Class II Medical Device (BK110035) Non-Pyrogenic – Sterile – Closed System

Monocyte Solution

System produces PRP in which monocytes outnumber neutrophils

Simple, Quick, & Predictable

Small blood draw, easy to use, reproducible collection process

Low Inflammation

Eliminates nearly 100% of red blood cells and 95% of white blood cells

Comfortable

Proprietary MNC7 anti-coagulant produces physiologic pH, which reduces irritation

Eclipse PRP 22mL Product Specifications

Platelets concentration fold:

RBC (10/ul): 

WBC (10/ul):

Granulocytes %

Mononuclear cells %

PDGF (pg/ml)

VEGF (pg/ml)

 

x 4 – 5

0.0

0.2

8.5

86.2

2048

220

Safety Profile

Eclipse is an ISO 13485 and MDSAP certified manufacturer.

Eclipse Tropocells PRP is manufactured in an ISO 7 cleanroom, with critical phases performed in an ISO 5 environment.

Our gel separator PRP kits are made in an ISO 13485 certified and FDA registered facility.

Several validated and required tests* are performed by third party certifying agencies on our separator gel kit to ensure patient safety for autologous application:

  • Delayed Hypersensitivity Test (GMPT)
  • Cytotoxicity Test by Elution
  • Acute Systemic Toxicity Test

Over 800,000 patient cases have been safely performed worldwide with our system since 2013.

*To request copies of these tests please contact your Eclipse representative. PRP companies without these tests cannot guarantee safety or quality of the product.

Regulatory Status

All PRP products are considered Class II Medical Devices by the United States Food and Drug Administration. All products being sold for the purpose of collecting PRP for point of care autologous applications must obtain FDA Class II clearance by obtaining a 510(k) prior to being sold in the US.

Eclipse PRP® is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to a bony defect for improving handling characteristics.

510(k) number: BK110035

In the article titled “US Definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine”, Beitzel et al† have outlined the FDA’s stance on PRP and the implications for physicians wishing to add PRP to their practice.

†Beitzel, K; Allen, D; Apostolakos, J; Russell, RP; McCarthy, MB; Gallo, GJ; Cote, MP; Mazzocca, AD (February 2015). “US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine”. The Journal of Knee Surgery. 28 (1): 29–34.
doi:10.1055/s-0034-1390030. PMID 25268794.
BSI ISO Logo

Precautions

  1. PRP should be applied to the same patient from whom the blood was drawn.
  2. Storage of tubes containing blood at or below 0°C may result in tube breakage.
  3. Storage of tubes above 40°C may damage the gel stability.
  4. Do not use tubes if foreign matter is present.
  5. All anticoagulants are clear. 
  6. Do not use tubes after their expiration date.
  7. Do not re-sterilize and do not attempt to clean this product.
  8. Do not use products if Tyvek® medical package is already opened or damaged.

Risks

  • Infection
  • Bleeding
  • Nerve damage
  • Pain
  • Lack of result